Status:
COMPLETED
Predictive Value of suPAR and hsCRP on Postoperative Mortality in Cardiac Surgery
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Persimune
University of Copenhagen
Conditions:
Thoracic Surgery
Cardiac Surgical Procedures
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate whether preoperative soluble urokinase plasminogen activating receptor (suPAR) and High-sensitivity C-Reactive Protein (hsCRP) are independent markers of death after car...
Eligibility Criteria
Inclusion
- Planned elective on-pump cardiac surgery (isolated coronary artery bypass graft (CABG), single and multiple valvular procedures, combined CABG and valvular surgery, and others)
- Given informed consent on delivering a blood sample for the biobank.
Exclusion
- Peroperatively cancelling the surgery
- Sudden change to off-pump coronary artery bypass (OPCAB) surgery
- Death prior to surgery
- Project blood samples not available.
Key Trial Info
Start Date :
August 6 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2019
Estimated Enrollment :
951 Patients enrolled
Trial Details
Trial ID
NCT04292249
Start Date
August 6 2012
End Date
December 16 2019
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiothoracic Anaesthesiology, Rigshospitalet
Copenhagen, Denmark, 2100